AUROBINDO PHARMA USA gots Tentative Approval for PREGABALIN on JUNE14, 2016. Pregabalin is indicated for:
Neuropathic pain associated with diabetic peripheral neuropathy (DPN), Postherpetic neuralgia (PHN), Adjunctive therapy for adult patients with partial onset seizures, Fibromyalgia, Neuropathic pain associated with spinal cord injury.
LYRICA is branded formulation of Pregabalin. LYRICA launched by PF PRISM CV on December 30, 2004. LYRICA is available in capsule dosage form and in multiple strength (25MG , 50 MG, 75 MG, 100 MG, 150 MG, 200 MG, 225 MG, 300 MG).
ACTAVIS ELIZABETH, ALEMBIC PHARMS LTD, APOTEX INC, LUPIN LTD, MACLEODS PHARMS LTD, MYLAN PHARMS INC, SANDOZ INC , TEVA PHARMS, WATSON LABS INC, WOCKHARDT USA have already got tentative approval for Pregabalin in USA.
Follow the below link for formulation literature of pregabalin:
http://www.formulationdiary.com/Home/Details/PREGABALIN
Follow the below link for formulation literature of pregabalin:
http://www.formulationdiary.com/Home/Details/PREGABALIN
No comments:
Post a Comment